X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Panacea Biotech Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results   (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-15
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,2211,2481,6481,5412,0321,2371,3721,022 
Other income Rs m16337746086112200137 
Turnover Rs m2,3841,2851,7211,6012,1171,3491,5721,159 
Expenses Rs m2,0791,1711,3981,3109771,1291,2691,024 
Gross profit Rs m142782505791,055107103-2 
Depreciation Rs m162186177181170166166165 
Interest Rs m438298317285243250255263 
Profit before tax Rs m-295-369-170174727-197-118-293 
Tax Rs m190005000 
Profit after tax Rs m-314-369-170174722-197-118-293 
Gross profit margin %6.46.215.237.651.98.77.5-0.2 
Effective tax rate %-6.40.00.00.00.70.00.00.0 
Net profit margin %-14.1-29.6-10.311.335.5-15.9-8.6-28.6 
Diluted EPS Rs -5.1 -6.0 -2.8 2.8 11.8 -3.2 -1.9 -4.8  
Diluted EPS (TTM) Rs -10.6 -12.8 -14.5 -11.1 5.8 8.6 9.5 1.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare PANACEA BIOTECH With:   J.B.CHEMICALS  GSK PHARMA  CIPLA  ORCHID PHARMA LTD  GLENMARK PHARMA  

Compare PANACEA BIOTECH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends on a Firm Note; Asian Paints Rallies 4% on Strong Q2 Result(Closing)

Indian share markets rose 100 points in the afternoon session to finish in green for second consecutive day. At the closing bell, the BSE Sensex closed higher by 101 points.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

This Rs 71 Trillion Business Could Make or Break (Your) Wealth in the Next Decade(The 5 Minute Wrapup)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

Electric Vehicles: The Final Piece of the Puzzle(Smart Contrarian)

Oct 16, 2017

Just as there would be gainers from an electric vehicles boom, who possibly could be the biggest losers.

The Delusional Optimism of India's Real Estate Companies(Vivek Kaul's Diary)

Oct 16, 2017

This is a sector which hasn't gone anywhere in nearly six years, but those who run it continue to remain optimistic.

How Many Shares Should One Buy?(Daily Profit Hunter)

Oct 18, 2017

How much to buy is the biggest challenge after deciding what to buy. Here's your solution.

Companies Are Wary of Borrowing(Chart Of The Day)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2018
Get our special report, Multibagger Stocks Guide (2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Oct 24, 2017 03:34 PM

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - TEVA PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS